Clinical trial
Efficacy of Artesunate-amodiaquine, Dihydroartemisinin-piperaquine and Artemether-lumefantrine Combination Therapies for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Aged 6 to 59 Months in Maradi, Niger 2012-13
NCT01755559 is registered in ClinicalTrials.gov with Epicentre as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Artesunate-amodiaquine, Dihydroartemisinin-piperaquine and Artemether-lumefantrine Combination Therapies for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Children Aged 6 to 59 Months in Maradi, Niger 2012-13
- Lead sponsor
- Epicentre
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2013
- Completion date
- November 30, 2014
- Enrollment
- 663 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.